Aurinia Pharmaceuticals, Inc. (AUPH)
16.05
-0.36
(-2.19%)
USD |
NASDAQ |
Sep 15, 14:39
Aurinia Pharmaceuticals Price : 16.05 for Sept. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | 16.03 | 16.52 | 15.93 | 16.41 | 753477.0 |
| Sep 11, 2026 | 16.28 | 16.35 | 16.06 | 16.10 | 745441.0 |
| Sep 10, 2026 | 16.12 | 16.20 | 15.90 | 16.11 | 687406.0 |
| Sep 09, 2026 | 15.97 | 16.32 | 15.85 | 16.25 | 723296.0 |
| Sep 08, 2026 | 15.98 | 16.38 | 15.93 | 16.07 | 970280.0 |
| Sep 04, 2026 | 15.97 | 16.22 | 15.93 | 16.08 | 526595.0 |
| Sep 03, 2026 | 16.35 | 16.36 | 15.99 | 16.12 | 752561.0 |
| Sep 02, 2026 | 16.17 | 16.46 | 15.92 | 16.29 | 842415.0 |
| Sep 01, 2026 | 16.05 | 16.26 | 15.92 | 16.05 | 878851.0 |
| Aug 31, 2026 | 16.21 | 16.30 | 15.94 | 16.11 | 744268.0 |
| Aug 28, 2026 | 16.44 | 16.47 | 16.26 | 16.29 | 630879.0 |
| Aug 27, 2026 | 16.47 | 16.65 | 16.31 | 16.48 | 838413.0 |
| Aug 26, 2026 | 16.60 | 16.65 | 16.34 | 16.54 | 777987.0 |
| Aug 25, 2026 | 16.63 | 16.83 | 16.54 | 16.75 | 780583.0 |
| Aug 24, 2026 | 16.57 | 16.68 | 16.31 | 16.57 | 686275.0 |
| Aug 21, 2026 | 17.20 | 17.32 | 16.62 | 16.65 | 1.249M |
| Aug 20, 2026 | 16.60 | 17.80 | 16.60 | 17.27 | 2.637M |
| Aug 19, 2026 | 15.57 | 16.18 | 15.34 | 16.17 | 1.646M |
| Aug 18, 2026 | 15.29 | 15.36 | 15.15 | 15.30 | 718429.0 |
| Aug 17, 2026 | 15.42 | 15.59 | 15.07 | 15.29 | 1.002M |
| Aug 14, 2026 | 15.09 | 15.49 | 14.90 | 15.47 | 827253.0 |
| Aug 13, 2026 | 15.56 | 15.56 | 15.02 | 15.18 | 1.594M |
| Aug 12, 2026 | 15.40 | 15.58 | 15.21 | 15.45 | 854448.0 |
| Aug 11, 2026 | 15.50 | 15.59 | 15.31 | 15.37 | 730725.0 |
| Aug 10, 2026 | 15.70 | 15.94 | 15.42 | 15.45 | 1.050M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| enGene Therapeutics, Inc. | 1.89 |
| Medicus Pharma Ltd. | 0.152 |
| Xenon Pharmaceuticals, Inc. | 56.50 |
| Psyence Biomedical Ltd. | 5.80 |
| Altimmune, Inc. | 3.265 |
Price Related Metrics
| PE Ratio | 7.016 |
| PS Ratio | 7.024 |
| PEG Ratio | 0.0161 |
| Price to Book Value | 3.469 |
| Price to Free Cash Flow | 12.56 |
| Earnings Yield | 14.25% |
| Market Cap | 2.133B |
| PEGY Ratio | 0.0161 |
| Operating PE Ratio | 15.56 |
| Normalized PE Ratio | 7.016 |